{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:55:31Z","timestamp":1790628931068,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["pathophysiologyjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathophysiology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.pathophys.2017.02.005","type":"journal-article","created":{"date-parts":[[2017,2,11]],"date-time":"2017-02-11T07:15:38Z","timestamp":1486797338000},"page":"45-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["IL-10 and TGF-\u03b2: Roles in chondroprotective effects of Glucosamine in experimental Osteoarthritis?"],"prefix":"10.1016","volume":"24","author":[{"given":"Nermien E.","family":"Waly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Refaiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora M.","family":"Aborehab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathophys.2017.02.005_bib0005","doi-asserted-by":"crossref","first-page":"15040","DOI":"10.1038\/boneres.2015.40","article-title":"Current research on pharmacologic and regenerative therapies for osteoarthritis","volume":"4","author":"Zhang","year":"2016","journal-title":"Bone. Res."},{"issue":"1","key":"10.1016\/j.pathophys.2017.02.005_bib0010","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/art.21562","article-title":"Projections of US prevalence of arthritis and associated activity limitations","volume":"54","author":"Hootman","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.pathophys.2017.02.005_bib0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.joca.2011.01.019","article-title":"Osteoarthritis year 2010 in review: pharmacological therapies","volume":"19","author":"Berenbaum","year":"2011","journal-title":"Osteoarthr. Cartil."},{"issue":"4","key":"10.1016\/j.pathophys.2017.02.005_bib0020","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.joca.2011.01.021","article-title":"Osteoarthritis year 2010 in review: non-pharmacologic therapy","volume":"19","author":"Hawker","year":"2011","journal-title":"Osteoarthr. Cartil."},{"issue":"2","key":"10.1016\/j.pathophys.2017.02.005_bib0025","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/jps.23819","article-title":"Glucosamine dose\/concentration-effect correlation in the rat with adjuvant arthritis","volume":"103","author":"Aghazadeh-Habashi","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.pathophys.2017.02.005_bib0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jor.22445","article-title":"3rd, et al: intra-articular delivery of glucosamine for treatment of experimental osteoarthritis created by a medial meniscectomy in a rat model","volume":"32","author":"Gibson","year":"2014","journal-title":"J. Orthop. Res."},{"issue":"52","key":"10.1016\/j.pathophys.2017.02.005_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13520","article-title":"The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation","volume":"13","author":"Black","year":"2009","journal-title":"Health Technol. Assess."},{"issue":"7","key":"10.1016\/j.pathophys.2017.02.005_bib0040","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/00002512-200724070-00005","article-title":"Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis","volume":"24","author":"Bruyere","year":"2007","journal-title":"Drugs Aging"},{"issue":"12","key":"10.1016\/j.pathophys.2017.02.005_bib0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.17116\/terarkh2015871249-54","article-title":"[Use of ARTRA MSM FORTE in patients with knee osteoarthritis: results of a randomized open-label comparative study of the efficacy and tolerability of the drug]","volume":"87","author":"Alekseeva","year":"2015","journal-title":"Ter. Arkh."},{"issue":"2","key":"10.1016\/j.pathophys.2017.02.005_bib0050","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1271\/bbb.80418","article-title":"Effects of an oral administration of glucosamine-chondroitin-quercetin glucoside on the synovial fluid properties in patients with osteoarthritis and rheumatoid arthritis","volume":"73","author":"Matsuno","year":"2009","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"5","key":"10.1016\/j.pathophys.2017.02.005_bib0055","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3892\/etm.2011.298","article-title":"Effect of a glucosamine-based combination supplement containing chondroitin sulfate and antioxidant micronutrients in subjects with symptomatic knee osteoarthritis: a pilot study","volume":"2","author":"Nakasone","year":"2011","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.pathophys.2017.02.005_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12937-015-0115-z","article-title":"Benefits of antioxidant supplements for knee osteoarthritis: rationale and reality","volume":"15","author":"Grover","year":"2016","journal-title":"Nutr. J."},{"issue":"3","key":"10.1016\/j.pathophys.2017.02.005_bib0065","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.maturitas.2014.04.015","article-title":"What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis?","volume":"78","author":"Henrotin","year":"2014","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.pathophys.2017.02.005_bib0070","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/joca.1999.0299","article-title":"Glucosamine HCl reduces equine articular cartilage degradation in explant culture","volume":"8","author":"Fenton","year":"2000","journal-title":"Osteoarthr. Cartil."},{"issue":"2","key":"10.1016\/j.pathophys.2017.02.005_bib0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/1529-0131(200102)44:2<351::AID-ANR53>3.0.CO;2-M","article-title":"Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1beta-mediated effects in rat chondrocytes","volume":"44","author":"Gouze","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.pathophys.2017.02.005_bib0080","first-page":"E116","article-title":"Evaluation of the validity of the Autism Spectrum Quotient (AQ) in differentiating high-functioning autistic spectrum disorder from schizophrenia","volume":"56","author":"Naito","year":"2010","journal-title":"Kobe J. Med. Sci."},{"issue":"3","key":"10.1016\/j.pathophys.2017.02.005_bib0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cyto.2007.06.001","article-title":"Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone","volume":"38","author":"Hulejova","year":"2007","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.pathophys.2017.02.005_bib0090","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1002\/art.38181","article-title":"Role of interleukin-10 in endochondral bone formation in mice: anabolic effect via the bone morphogenetic protein\/Smad pathway","volume":"65","author":"Jung","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.pathophys.2017.02.005_bib0095","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/bjh.12148","article-title":"A single intra-articular injection with IL-4 plus IL-10 ameliorates blood-induced cartilage degeneration in haemophilic mice","volume":"160","author":"van Meegeren","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.pathophys.2017.02.005_bib0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbadis.2008.01.006","article-title":"Role of transforming growth factor-beta superfamily signaling pathways in human disease","volume":"1782","author":"Gordon","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.pathophys.2017.02.005_bib0105","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1210\/er.2004-0001","article-title":"Transforming growth factor-beta1 to the bone","volume":"26","author":"Janssens","year":"2005","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.pathophys.2017.02.005_bib0110","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nm.3143","article-title":"Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis","volume":"19","author":"Zhen","year":"2013","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.pathophys.2017.02.005_bib0115","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.pathophys.2017.02.005_bib0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.vascn.2011.10.002","article-title":"Establishment of a novel objective and quantitative method to assess pain-related behavior in monosodium iodoacetate-induced osteoarthritis in rat knee","volume":"65","author":"Nagase","year":"2012","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.pathophys.2017.02.005_bib0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2014.05.048","article-title":"Efficacy of drugs with different mechanisms of action in relieving spontaneous pain at rest and during movement in a rat model of osteoarthritis","volume":"738","author":"Ishikawa","year":"2014","journal-title":"Eur. J Pharmacol."},{"issue":"4","key":"10.1016\/j.pathophys.2017.02.005_bib0130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3923\/jas.2010.248.260","article-title":"Chondroprotective effect of Zerumbone on Monosodium Iodoacetate induced osteoarthritis in rats","volume":"10","author":"Al-Saffar","year":"2010","journal-title":"Journal of Applied Sciences"},{"key":"10.1016\/j.pathophys.2017.02.005_bib0135","series-title":"Anesthesia and Analgesia in the Laboratory Rat","first-page":"627","author":"Vogler","year":"2006"},{"issue":"1","key":"10.1016\/j.pathophys.2017.02.005_bib0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","article-title":"Osteoarthritis cartilage histopathology: grading and staging","volume":"14","author":"Pritzker","year":"2006","journal-title":"Osteoarthr. Cartil."},{"issue":"18","key":"10.1016\/j.pathophys.2017.02.005_bib0145","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1001\/archinte.162.18.2113","article-title":"Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study","volume":"162","author":"Pavelka","year":"2002","journal-title":"Arch. Intern. Med."},{"issue":"10","key":"10.1016\/j.pathophys.2017.02.005_bib0150","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.284.10.1241","article-title":"Efficacy of glucosamine and chondroitin for treatment of osteoarthritis","volume":"284","author":"McAlindon","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.pathophys.2017.02.005_bib0155","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2147\/CIA.S93077","article-title":"Glucosamine-containing supplement improves locomotor functions in subjects with knee pain: a randomized, double-blind, placebo-controlled study","volume":"10","author":"Kanzaki","year":"2015","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.pathophys.2017.02.005_bib0160","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.biopha.2016.02.005","article-title":"Chondroprotective effects of the combination chondroitin sulfate-glucosamine in a model of osteoarthritis induced by anterior cruciate ligament transection in ovariectomised rats","volume":"79","author":"Terencio","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.pathophys.2017.02.005_bib0165","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.prp.2015.01.008","article-title":"Exercise modulates the expression of IL-1beta and IL-10 in the articular cartilage of normal and osteoarthritis-induced rats","volume":"211","author":"Rojas-Ortega","year":"2015","journal-title":"Pathol. Res. Pract."},{"issue":"3","key":"10.1016\/j.pathophys.2017.02.005_bib0170","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cyto.2008.10.012","article-title":"IL-10 overexpression differentially affects cartilage matrix gene expression in response to TNF-alpha in human articular chondrocytes in vitro","volume":"44","author":"Muller","year":"2008","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.pathophys.2017.02.005_bib0175","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1172\/JCI118286","article-title":"IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes","volume":"96","author":"Lacraz","year":"1995","journal-title":"J. Clin. Invest."}],"container-title":["Pathophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092846801630058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092846801630058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T15:37:08Z","timestamp":1568821028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092846801630058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S092846801630058X"],"URL":"https:\/\/doi.org\/10.1016\/j.pathophys.2017.02.005","relation":{},"ISSN":["0928-4680"],"issn-type":[{"value":"0928-4680","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-10 and TGF-\u03b2: Roles in chondroprotective effects of Glucosamine in experimental Osteoarthritis?","name":"articletitle","label":"Article Title"},{"value":"Pathophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathophys.2017.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}